Beta Bionics, Inc. · NASDAQ:BBNX
Hopman Mark sold 775 Beta Bionics, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Hopman Mark (Chief Commercial Officer) sold 775 Beta Bionics, Inc. shares at US$16.22 for US$12,571 under a trading plan, leaving 54,143 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 775 shares
- Price
- US$16.22
- Value
- US$12,571
- Holding after
- 54,143 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Option exercise | 775 | US$5.10 | 54,918 | Direct |
| Nov 16, 2026 | Common Stock | Sale | 775 | US$16.22 | 54,143 | Direct |
Source
Download original · View original at SEC
Related
- Beta Bionics, Inc.
- Hopman Mark
- Beta Bionics, Inc. shareholders
- Form 4 · Hopman Mark · Nov 4, 2026
- Form 4 · Hopman Mark · Oct 28, 2026
- Form 4 · Hopman Mark · Oct 16, 2026
- Form 4 · Hopman Mark · Oct 5, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026
- Schedule 13G/A · Divisadero Street Capital Management, LP · Nov 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 16, 2026
- Form 4 · Feider Stephen · Nov 13, 2026
- Form 4 · Feider Stephen · Nov 12, 2026
- Form 4 · Feider Stephen · Nov 9, 2026